Skip to main content
SpringerLink
Log in

Effect of Taizhi’an capsule combined with Simvastatin on hyperlipidemia in diabetic patients

  • Original Articles
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Objective: To evaluate the effectiveness and safety of Taizhi’an (TZA) capsule combined with Simvastatin (Sim) in treating hyperlipidemia in diabetes mellitus (DM) patients.Methods: Eighty cases of type 2 DM patients with hyperlipidemia were randomized into two groups, 40 in each group. The patients in the treated group took orally TZA capsules at the dose of 0.9 g 3 times a day and Sim 10 mg at bedtime. And the patients in the control group were treated with Sim 20 mg alone at bedtime. Both regimens lasted for 12 weeks. Before and after the study the changes of blood lipid levels and adverse reaction were investigated.Results: The serum levels of total cholesterol (TC), triglycerides (TG) and low density lipoprotein-cholesterol (LDL-C) were decreased respectively by 28.8%, 18.2% and 26.3% in the treated group; and by 29.4%, 19.4% and 24.6% in the control group. On the contrary, high density lipoprotein-cholesterol (HDL-C) was increased by 23.5% in the treated group and by 29.4% in the control group. All these changes were statistically significant before and after treatment (allP<0.05), but they did not differ statistically between the two groups (P>0.05). There was no significant changes in hemoglobin A1c (HbA1c). Patients in the treated group did not develop any adverse reactions. However, ALT was found to be higher above the normal range in 5% of the patients in the control group.Conclusion: In treating hyperlipidemia in DM patients, combination of TZA with Sim 10 mg taken daily achieved satisfactory efficacy which was similar to Sim 20 mg daily alone. But the combination therapy conducted in the treated group proved to be better in safety, and could overcome adverse reactions resulting from Sim that was seen in the control group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Dong YH, Qian RU editors. Contemporary treatment of diabetes and its complications. Jinan: Shandong Scientific and Technologic Publishing House, 1994: 121–122.

    Google Scholar 

  2. Mukamal KJ, Nesto RW, Cohen MC, et al. Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care 2001; 24: 1422–1427.

    Article  PubMed  CAS  Google Scholar 

  3. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

    Article  Google Scholar 

  4. Qian RL. New criteria for the diagnosis and classification of diabetes mellitus. Chin J Diabetes 2000; 8(1): 5–6.

    Google Scholar 

  5. Fagan TC, Sowers J. Type 2 diabetes mellitus: greater cardiovascular risks and greater benefits of therapy (Editorial). Arc Intern Med 1999; 159: 1033–1034.

    Article  CAS  Google Scholar 

  6. Steven AG, Louis C, Hanna Z, et al. Cost-effectiveness of treating hyperlipidemia in the presence of diabetes. Circulation 2000; 102: 722–727.

    Google Scholar 

  7. American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care 2004; 27: S68-S71.

    Article  Google Scholar 

  8. He H, Liu QN, Wang HF, et al. Effect of Atorvastatin on hyperlipidemia in senile type 2 diabetics. Chin Hosp Pharm J 2004; 24(4): 232–233.

    Google Scholar 

  9. Qi BL. Cheng B, Zhang QH. Comparison of effects of Taizhian capsule and pravastatin on vascular endothelial function in senile patients with coronary heart disease. Chin J Integr Tradit West Med 2004; 24(5): 404–407.

    Google Scholar 

  10. Miao YD, Liu J. Evaluation for the efficacy of Taizhian in the treatment of primary hyperlipidemia in aged patients. Chin Pharm Health J 2003; 24(1): 32–34.

    Google Scholar 

  11. Li QL, Zhang YF. Clinical observation on effect of Taizhian capsule in treating 150 patients with hyperlipidemia. Chin J Integr Tradit West Med 2003; 23(5): 335–337.

    Google Scholar 

  12. Pedersen TR, Tobert JA. Simvastatin: a review. Expert Opin Pharmacother 2004;5(12): 2583–2596.

    Article  PubMed  CAS  Google Scholar 

  13. Ovesna Z, Vachalkova A, Horvathova K, et al. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview. Neoplasma 2004; 51(5): 327–333.

    CAS  Google Scholar 

  14. Li GH, Yang ZN. Experimental studies on antihyperlipidemia effects of two compositions from hawthorn in mice. Chin Tradit Herbal Drugs 2002; 33(1): 50–52.

    CAS  Google Scholar 

  15. Yin XD, Zhao HR. Progress in ursolic acid research. Chin Pract J Tradit West Med 2004; 17(24): 3830–3832.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan

    Gao Feng

  2. Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, China

    Hu Xiu-fen

Authors
  1. Gao Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hu Xiu-fen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gao Feng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feng, G., Xiu-fen, H. Effect of Taizhi’an capsule combined with Simvastatin on hyperlipidemia in diabetic patients. Chin. J. Integr. Med. 12, 24–28 (2006). https://doi.org/10.1007/BF02857425

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02857425

Key words

Search

Navigation